Fig. 3From: Nuclear HER3 expression improves the prognostic stratification of patients with HER1 positive advanced laryngeal squamous cell carcinomaRelapse-free and overall survival probabilities according to HER phenotypes of LSCC of bioradiotherapy with cetuximab and upfront surgery with or without postoperative radio/chemo-radiotherapy treated patient groupsBack to article page